Increasing survival time decreases the cost-effectiveness of using "test & treat to eliminate HIV epidemics

  • Received: 01 November 2012 Accepted: 29 June 2018 Published: 01 August 2013
  • MSC : Primary: 92D30, 92C60; Secondary: 92C50.

  • Treating HIV-infected individuals reduces their viral load, consequently increasing their survival time and decreasing their infectivity.It has been proposed that universal testing and treatment (i.e., universal ``test & treat'') could lead to HIV elimination and would be extremely cost-effective.It is now being debated whether to use a universal ``test and treat'' approach in the ``real-world'' as a prevention strategy to control HIV epidemics.However current modeling predictions of the impact, and cost-effectiveness, of universal ``test & treat'' strategies are based on an unrealistically short survival time for treated individuals.Here we use mathematical modeling and a longer, more realistic, survival time.We model the potential impact of a universal ``test & treat'' strategy in South Africa.Our results show that increasing the length of the survival time on treatment, although beneficial to individuals, reduces the probability of eliminating HIV and decreases the cost-effectiveness of using universal ``test & treat'' strategies.Therefore our results show that individual-level benefits and public health benefits will conflict when using ``test & treat'' strategies to reduce HIV transmission.

    Citation: Bradley G. Wagner, Brian J. Coburn, Sally Blower. Increasing survival time decreases the cost-effectiveness of using "test & treat to eliminate HIV epidemics[J]. Mathematical Biosciences and Engineering, 2013, 10(5&6): 1673-1686. doi: 10.3934/mbe.2013.10.1673

    Related Papers:

  • Treating HIV-infected individuals reduces their viral load, consequently increasing their survival time and decreasing their infectivity.It has been proposed that universal testing and treatment (i.e., universal ``test & treat'') could lead to HIV elimination and would be extremely cost-effective.It is now being debated whether to use a universal ``test and treat'' approach in the ``real-world'' as a prevention strategy to control HIV epidemics.However current modeling predictions of the impact, and cost-effectiveness, of universal ``test & treat'' strategies are based on an unrealistically short survival time for treated individuals.Here we use mathematical modeling and a longer, more realistic, survival time.We model the potential impact of a universal ``test & treat'' strategy in South Africa.Our results show that increasing the length of the survival time on treatment, although beneficial to individuals, reduces the probability of eliminating HIV and decreases the cost-effectiveness of using universal ``test & treat'' strategies.Therefore our results show that individual-level benefits and public health benefits will conflict when using ``test & treat'' strategies to reduce HIV transmission.


    加载中
    [1] Science, 287 (2000), 650-654.
    [2] Curr. Drug Targets Infect. Disord., 3 (2003), 345-353.
    [3] Int. Stat. Rev., 62 (1994), 229-243.
    [4] Lancet, 373 (2009), 1077; author reply, 1080-1071.
    [5] N. Engl. J. Med., 365 (2011), 493-505.
    [6] PLoS ONE, 5 (2010), e11068.
    [7] JAMA, 301 (2009), 2380-2382.
    [8] Wiley Series in Mathematical and Computational Biology, John Wiley & Sons, Ltd., Chichester, 2000.
    [9] AIDS, 24 (2010), 729-735.
    [10] J. Acquir. Immune Defic. Syndr., 55 (2010), S116-121.
    [11] Lancet, 358 (2001), 404-409.
    [12] Clin. Infect. Dis., 52 (2011), 793-800.
    [13] Lancet, 373 (2009), 9-11.
    [14] Lancet, 373 (2009), 48-57.
    [15] PLoS ONE, 7 (2012), e30216.
    [16] Lancet, 357 (2001), 1149-1153.
    [17] Lecture Notes in Biomathematics, 56, Springer-Verlag, Berlin, 1984.
    [18] J. Infect. Dis., 198 (2008), 59-67.
    [19] Ann. Intern. Med., 155 (2011), 209-216.
    [20] Lancet, 368 (2006), 531-536.
    [21] (2007).
    [22] (2011).
    [23] Math. Biosci., 180 (2002), 29-48.
    [24] Lancet Infect. Dis., 2 (2002), 487-493.
    [25] AIDS, 24 (2010), 775-776.
    [26] Lancet, 376 (2010), 953-954.
    [27] PLoS ONE, 7 (2012), e41212.
  • Reader Comments
  • © 2013 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(1462) PDF downloads(451) Cited by(1)

Article outline

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog